Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Wong

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
NPJ Breast Cancer|September 12, 2019
Success rates of re-excision after positive margins for invasive lobular carcinoma of the breastMerisa L Piper, Jasmine Wong, Kelly Fahrner-Scott, et al.
European Journal of Medicinal Chemistry|July 18, 2018
Discovery of the cancer cell selective dual acting anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131)Cheng Shang See, Mayumi Kitagawa, Pei-Ju Liao, et al.
Journal of Cardiothoracic Surgery|September 7, 2019
Case report: recurrent metastatic breast cancer in internal mammary dissection bed discovered at the time of coronary bypassGavitt A Woodard, Hannah Lee, Daffolyn Rachael Fels Elliott, et al.
American Journal of Physiology. Renal Physiology|September 21, 2023
Kidney functional reserve and damage biomarkers in subclinical chronic kidney disease and acute kidney injuryKylie M Taylor, Amy Y M Au, Sanjeeva Herath, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2018
Prodrugs of the cancer cell selective anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131) are orally efficacious in a mouse model of resistant colon cancerCheng Shang See, Mayumi Kitagawa, Pei-Ju Liao, et al.
Plastic and Reconstructive Surgery. Global Open|February 13, 2023
Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction OutcomesLaura L Barnes, Rob Foster, Rita A Mukhtar, et al.
Breast Cancer Research and Treatment|July 23, 2020
Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breastMary Kathryn Abel, Kelly Fahrner-Scott, Jasmine Wong, et al.
Annals of Surgical Oncology|July 18, 2023
Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic TherapyHarriet T Rothschild, Elle N Clelland, Firdows Mujir, et al.
American Journal of Surgery|July 6, 2020
Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greaterMary Kathryn Abel, Case E Brabham, Ruby Guo, et al.
The British Journal of Dermatology|February 10, 2023
A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblingsMingfeng Li, Kenneth Lay, Andreas Zimmer, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
NPJ Breast Cancer|September 12, 2019
Success rates of re-excision after positive margins for invasive lobular carcinoma of the breastMerisa L Piper, Jasmine Wong, Kelly Fahrner-Scott, et al.
European Journal of Medicinal Chemistry|July 18, 2018
Discovery of the cancer cell selective dual acting anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131)Cheng Shang See, Mayumi Kitagawa, Pei-Ju Liao, et al.
Journal of Cardiothoracic Surgery|September 7, 2019
Case report: recurrent metastatic breast cancer in internal mammary dissection bed discovered at the time of coronary bypassGavitt A Woodard, Hannah Lee, Daffolyn Rachael Fels Elliott, et al.
American Journal of Physiology. Renal Physiology|September 21, 2023
Kidney functional reserve and damage biomarkers in subclinical chronic kidney disease and acute kidney injuryKylie M Taylor, Amy Y M Au, Sanjeeva Herath, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2018
Prodrugs of the cancer cell selective anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131) are orally efficacious in a mouse model of resistant colon cancerCheng Shang See, Mayumi Kitagawa, Pei-Ju Liao, et al.
Plastic and Reconstructive Surgery. Global Open|February 13, 2023
Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction OutcomesLaura L Barnes, Rob Foster, Rita A Mukhtar, et al.
Breast Cancer Research and Treatment|July 23, 2020
Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breastMary Kathryn Abel, Kelly Fahrner-Scott, Jasmine Wong, et al.
Annals of Surgical Oncology|July 18, 2023
Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic TherapyHarriet T Rothschild, Elle N Clelland, Firdows Mujir, et al.
American Journal of Surgery|July 6, 2020
Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greaterMary Kathryn Abel, Case E Brabham, Ruby Guo, et al.
The British Journal of Dermatology|February 10, 2023
A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblingsMingfeng Li, Kenneth Lay, Andreas Zimmer, et al.
Pageof 5